MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jbm.s386594

Медицинская библиотека · Journal of blood medicine · 2022

Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia.

Habbash Fatema, Al-Bati Wegdan, Al-Hashim Howra, Aldossari Maryam, Alali Ahmed, Alalyani Khalid, Al-Ebrahim Zainab, Hamed Nouf, Eraqe Samma, Binayfan Ziyad, Al Marri Azzam, Aljaber Thamer

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Endocrinopathies and metabolic complications are common in beta thalassemia major patients receiving blood transfusions. Chelation therapy has a role in preventing or delaying such complications. However, patients may face difficulties adhering to chelation therapy for several reasons.

AIM: To evaluate endocrine complications in beta thalassemia major patients (2-30 years) in the Eastern Province of Saudi Arabia and compare the onset of endocrine complications among compliant and noncompliant patients. Moreover, we assessed the barriers that hinder compliance with chelating therapy.

METHODS

A cross-sectional study was conducted on 89 patients (43 males and 46 females) aged 2 to 30 years attending different hospitals in the Eastern Province of Saudi Arabia. A semi-structured questionnaire was used to collect demographic data and medical histories. The questionnaires were completed by face-to-face interviews with the patients or their caregivers, and the required laboratory data were retrieved from the medical records of patients.

RESULTS

The most prevalent abnormality was underweight detected in (40.9%) of patients, followed by subclinical hypothyroidism (37.7%), short stature (35.2%), hypothyroidism in (17.0%) and diabetes mellitus in (13.6%). A significant difference between those who were compliant with iron chelation therapy and those who were not in terms of the prevalence of short stature (P value=0.05) and hypothyroidism (P value=0.05). The percentage of patients who were not compliant with chelation therapy was 21.6% and 9.1% of patients were not taking them at all.

CONCLUSION

Despite the role of chelation therapy in the management of iron overload, the risk of secondary endocrine and metabolic complications remained considerable. Subclinical hypothyroidism and short stature were the most frequent endocrine complications encountered in this study.

Для цитирования: Habbash Fatema, Al-Bati Wegdan, Al-Hashim Howra, Aldossari Maryam, Alali Ahmed, Alalyani Khalid, Al-Ebrahim Zainab, Hamed Nouf, Eraqe Samma, Binayfan Ziyad, Al Marri Azzam, Aljaber Thamer. Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia.. Journal of blood medicine. 2022. DOI: 10.2147/jbm.s386594.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.